We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site, or closing this box, you consent to our use of cookies.

X

2018 Press Releases

Webcast ImageWebcast
West Pharmaceutical Services at UBS Global Healthcare Conference  (Replay)
05/21/18 at 1:00 p.m. ET
West Pharmaceutical Services at UBS Global Healthcare Conference
Monday, May 21, 2018 1:00 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Keyword Search
2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011
DateTitle 
05/24/18West Announces Participation in Upcoming June Investor Conferences
EXTON, Pa., May 24, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that its Management Team will present an overview of the Company's business at two investor conferences in June. Management will present at the Jefferies 2018 Global Healthcare Conference in New York, New York at 8:00 a.m. EDT on Tuesday, June 5, 2018; and at the Goldman Sachs 39th Annual Global Healthcare Conference ... 
Printer Friendly Version
05/03/18West Announces Third-Quarter Dividend, Increase to Fourth-Quarter Dividend and Participation in Upcoming Investor Conferences
EXTON, Pa., May 3, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors has approved a third-quarter 2018 dividend of $0.14 per share.  The dividend will be paid on August 1, 2018, to shareholders of record as of July 18, 2018. In addition, the Board of Directors has approved a fourth-quarter dividend of $0.15 per share, a 7.1% increase over the $0.14 per share declared for each of the four preceding quarters.  This is the t... 
Printer Friendly Version
04/26/18West Announces First-Quarter 2018 Results
- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa., April 26, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first-quarter 2018 and reaffirmed financial guidance for full-year 2018.  Executive Summary First-quarter 2018 reported net sales of $415.7 million grew 7.2% over the prior-year quarter.  At constant currency, organic sales growth was 0.2%. First-quarter 201... 
Printer Friendly Version
04/12/18West to Host First-Quarter 2018 Conference Call
EXTON, Pa., April 12, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release first-quarter 2018 financial results before the market opens on Thursday, April 26, 2018, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time. To participate on the call, please dial 877-930-8295 (U.S.) or 253-336-8738 (International)... 
Printer Friendly Version
03/19/18West to Showcase DAIKYO PLASCAP® RUV One-Step Press-Fit Vial Closure Solution at PDA Annual Meeting
West to present several scientific posters highlighting expertise in ensuring quality, sterility and stability of injectable drug products ORLANDO, Fla., March 19, 2018 /PRNewswire/ -- (Booth #501) – West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced it will showcase Daikyo's new innovation –  the DAIKYO PLASCAP® RUV one-step press-fit vial closure solution for serum applications – at the Parenteral Dru... 
Printer Friendly Version
03/02/18West Chief Financial Officer William Federici Announces Plans to Retire
EXTON, Pa., March 2, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced William Federici, Senior Vice President, Chief Financial Officer and Treasurer, has communicated his intention to retire later this year. West has commenced an external search for a successor. "With our company in a strong financial position and well-poised for future growth, and... 
Printer Friendly Version
02/26/18West Appoints Silji Abraham Chief Digital and Transformation Officer
EXTON, Pa., Feb. 26, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced Silji Abraham has been appointed Senior Vice President and Chief Digital and Transformation Officer, and will be responsible for driving a digital transformation at West to improve business performance across the enterprise. Effective February 26, 2018, Mr. Abraham will serve on the senior leadership team, and overse... 
Printer Friendly Version
02/15/18West Announces Fourth-Quarter and Full-Year 2017 Results and Announces Quarterly Dividend
- Conference Call Scheduled for 9 a.m. EST Today - EXTON, Pa., Feb. 15, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2017 and provided financial guidance for full-year 2018.  Executive Summary Fourth-quarter 2017 reported net sales of $415.6 million grew 8.7% over the prior-year quarter. At constant currency, organic sales growth was 4.5%. Excluding im... 
Printer Friendly Version
02/07/18SelfDose™ Patient-Controlled Injector Named as Recipient of Pharmapack Exhibitor Innovation Award
West Pharmaceutical Services, Inc. to showcase SelfDose injector among other advancements in integrated containment and drug delivery at Pharmapack Europe 2018 PARIS, Feb. 7, 2018 /PRNewswire/ -- Booth #D20 -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that its SelfDose™ Patient-Controlled Injector was named a recipient of a 2018 Pharmapack Exhibitor Innovation Award. The honor was presented to ... 
Printer Friendly Version
02/01/18West to Host Fourth-Quarter and Full-Year 2017 Conference Call
EXTON, Pa., Feb. 1, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release fourth-quarter and full-year 2017 financial results before the market opens on Thursday, February 15, 2018, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time. To participate on the call, please dial 877-930-8295 (U.S.) or 253-336-8738... 
Printer Friendly Version
West Pharma Callout
Contact Investor Relations